Search - tctmd.com

Displaying 361 - 380 of 693

Sort: Relevancy | Date

Presentation TCT 2015

Sirolimus-Eluting Angioplasty Balloon for In-Stent Restenosis (SABRE Trial): Six-Month Clinical and Angiographic Results

Presenter: Andrea Abizaid, Daniel Burkhoff, Juan F. Granada

October 14, 2015

Presentation TCT 2015

A Randomized Comparison Among Drug Eluting Balloon, Drug Eluting Stents, and Conventional Balloon Angioplasty for Lesions in the Distal Internal Pudendal Artery in Patients with Erectile Dysfunction: The Perfect-3 Study

Presenter: Andrea Abizaid, Daniel Burkhoff, Tzung-Dau Wang

October 14, 2015

News Industry News

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

October 14, 2015

News Conference News TCT 2015

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

October 14, 2015

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

News Industry News

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

October 14, 2015

Presentation TCT 2015

TCT 26: Balloon Pulmonary Angioplasty Driven by Combined Assessment of Intraarterial Anatomy and Physiology in Patients With Nonoperable Distal Chronic Thromboembolic Pulmonary Hypertension

Presenter: John P. Cheatham, Carlos Pedra, Marek Roik

October 13, 2015

Presentation TCT 2015

Clinical Trial Debate: Do DCBs Work for the BTK Indication? Yes, Perform DCB Angioplasty of BTK Lesions Correctly and They Work!

Presenter: Gary M. Ansel, J. A. Mustapha, Francesco Liistro

October 12, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

Presentation TCT 2015

Cath Lab Room Setup and Basic Equipment (Guiding Catheters, Wires, and Balloons)

Presenter: Robert T. Pyo, Bonnie H. Weiner

October 11, 2015

News Industry News

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

October 06, 2015

News Daily News

Sheathless Guide Catheter Safe, Effective in Transradial Primary PCI

Yael L. Maxwell

September 30, 2015

News Industry News

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

September 30, 2015

News Daily News

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

L.A. McKeown

September 23, 2015

News Opinion Fellow Talk

The Faith of ‘Investing’ in Chronic Total Occlusion Interventions

Henry Quevedo, MD

September 22, 2015

News Daily News

ProGlide Tops Prostar XL for Access-Site Closure After Transfemoral TAVR

September 09, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Industry News

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

July 29, 2015

Advertisement

Sirolimus-Eluting Angioplasty Balloon for In-Stent Restenosis (SABRE Trial): Six-Month Clinical and Angiographic Results

A Randomized Comparison Among Drug Eluting Balloon, Drug Eluting Stents, and Conventional Balloon Angioplasty for Lesions in the Distal Internal Pudendal Artery in Patients with Erectile Dysfunction: The Perfect-3 Study

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

IN.PACT SFA: Benefits of DCB Persist at 2 Years

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

TCT 26: Balloon Pulmonary Angioplasty Driven by Combined Assessment of Intraarterial Anatomy and Physiology in Patients With Nonoperable Distal Chronic Thromboembolic Pulmonary Hypertension

Clinical Trial Debate: Do DCBs Work for the BTK Indication? Yes, Perform DCB Angioplasty of BTK Lesions Correctly and They Work!

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

Cath Lab Room Setup and Basic Equipment (Guiding Catheters, Wires, and Balloons)

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

Sheathless Guide Catheter Safe, Effective in Transradial Primary PCI

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

The Faith of ‘Investing’ in Chronic Total Occlusion Interventions

ProGlide Tops Prostar XL for Access-Site Closure After Transfemoral TAVR

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content